Search

everythinglearnresearchcommunity

for

Search:↓

High dose rate electronic brachytherapy is an effective and safe non-surgical treatment for nonmelanoma skin cancer with good cosmetic results after three years.

Midazolam reduces PTSD-like behavior in rats by acting on specific brain receptors.

Lower illness acceptance is linked to more body dysmorphic disorder symptoms in patients with body modifications.

SIG-1451 could be a promising new treatment for atopic dermatitis.

BFNB could be a promising treatment for hair growth.

5-Bromo-3,4-dihydroxybenzaldehyde could potentially help hair growth by activating certain cell pathways and inhibiting others.

Adjusting minoxidil dosage may be safer than using bicalutamide for hair loss in women.

Corneal health relies on cell migration and cooperation with the lacrimal gland, not Bmi1+ cells, and Eda gene mutations can cause dry eye disease.

The research found a link between certain molecular features and the biological activity of BC3, which can help identify or create new active compounds.

A new method accurately measures cell changes in breast cancer.

Dabrafenib can cause skin growths and sometimes low-grade skin cancer.

MK-386 lowers DHT in blood and skin but not in semen.

Tofacitinib helps improve skin conditions in people with Down syndrome, especially alopecia areata.

Baricitinib for severe alopecia areata is generally safe, with common side effects like infections and acne, and low rates of serious complications.

KRT14 gene variants cause dermatopathia pigmentosa reticularis, affecting nails, teeth, and hair.

The scaffold effectively prevents melanoma relapse and aids wound healing.

Dimethylarsinic acid speeds up skin tumor growth in certain mice.

Baricitinib successfully treated myasthenia gravis and alopecia in a patient.

OR101 may effectively treat atopic dermatitis and similar skin conditions.

A man developed an allergic skin reaction after using brimonidine for rosacea.

CT-707 is effective and safe for treating certain Chinese lung cancer patients.

A specific genetic marker is linked to male pattern baldness in Han Chinese men.

The document concludes that detailed clinical descriptions of seven family cases help understand dominant dystrophic epidermolysis bullosa's symptoms and inheritance.

A chemical called 5-Bromo-2′-deoxyuridine caused rapid hair loss in mice by killing certain skin cells through a specific cell death pathway.

Some breast cancer treatments cause hair loss similar to male pattern baldness, which can be improved with minoxidil.

Eflornithine improved symptoms in Bachmann–Bupp Syndrome patients.

A new MTX2 gene mutation caused a severe genetic disorder in a young Chinese girl.

Skin disease activity scores can help decide when skin symptoms no longer affect the quality of life in patients with mild dermatomyositis.